Figure 3From: Tumor and red bone marrow dosimetry: comparison of methods for prospective treatment planning in pretargeted radioimmunotherapy 3D-RD-based (A), blood-based (B), and 2D cranium-based (C) absorbed dose in the red bone marrow versus the grade of platelet toxicity. AD RBM = absorbed dose red bone marrow.Back to article page